Label-free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals-Reference-Cited by-同舟云学术

Label-free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals

Published:2016-12 Issue:12 Volume:10 Page:1225-1241
ISSN:1862-8346
Container-title:PROTEOMICS - Clinical Applications
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Wang Jingxin¹,Cunningham Robert²,Zetterberg Henrik³⁴⁵,Asthana Sanjay⁶⁷⁸,Carlsson Cynthia⁶⁷⁸,Okonkwo Ozioma¹⁶⁷⁸,Li Lingjun¹⁹¹⁰¹¹

Affiliation:

1. Neuroscience Training Program; University of Wisconsin-Madison; Madison WI USA

2. Thermo Fisher Scientific; Rockford IL

3. Clinical Neurochemistry Laboratory; Sahlgrenska University Hospital; Mölndal Sweden

4. Department of Psychiatry and Neurochemistry; Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg; Mölndal Sweden

5. Department of Molecular Neuroscience; UCL Institute of Neurology; Queen Square London UK

6. Wisconsin Alzheimer's Disease Research Center; University of Wisconsin School of Medicine and Public Health; Madison WI USA

7. Geriatric Research Education and Clinical Center; Wm. S. Middleton Veterans Hospital; Madison WI USA

8. Wisconsin Alzheimer's Institute; University of Wisconsin School of Medicine and Public Health; Madison WI USA

9. School of Pharmacy; University of Wisconsin-Madison; Madison WI USA

10. Department of Chemistry; University of Wisconsin-Madison; Madison WI USA

11. School of Life Sciences; Tianjin University; Tianjin China

Funder

National Institutes of Health

NIH-NCRR

Publisher

Wiley

Subject

Clinical Biochemistry

Reference70 articles.

1. 2015 Alzheimer's disease facts and figures;Alzheimer's;Alzheimers Dement,2015

2. Alzheimer's disease;Blennow;Lancet,2006

3. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease;McKhann;Alzheimers Dement,2011

4. Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology;Olsson;Clin. Chem.,2005

5. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease;Hampel;Alzheimers Dement,2008

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer’s Disease;International Journal of Molecular Sciences;2024-08-18

2. Profiling Human Cerebrospinal Fluid (CSF) Endogenous Peptidome in Alzheimer’s Disease;Methods in Molecular Biology;2024

3. The Role of CSF Transthyretin in Human Alzheimer's Disease: Offense, Defense, or not so Innocent Bystander;Journal of Integrative Neuroscience;2023-11-06

4. Integrating intracellular and extracellular proteomic profiling for in‐depth investigations of cellular communication in a model of prostate cancer;PROTEOMICS;2023-05-24

5. Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer’s disease biomarkers;Cell Reports Medicine;2023-04